ORGO

Organogenesis Holdings INC

-$213.0M

Net Activity

Institutions Holding

121

Popularity Rank

#4066

Avg Weight

0.04%

Total Value

$146.8M

Ownership Trend

121 institutions currently hold ORGO, with 47 net buyers and 88 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

88

Net Buying Institutions

47

Key Holders

View all 121 holding institutions

Quarterly Activity

Recent Activity

+$75.1M

Total Buy Value

$186.6M

Total Sell Value

New buy13
Trim49
Add34
Sold out39

47

Net Buyers

88

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ORGANOGENESIS HOLDINGS INC (ORGO)?
Major stakeholders currently include Morgan Stanley ($27.5M), Soleus Capital Management, L.P. ($23.9M), BlackRock, Inc. ($11.6M). Based on the latest 13F filings, there are a total of 121 tracked investment funds and institutions maintaining positions in ORGO.
What is the overall institutional sentiment toward ORGO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $213.0M, driven by 47 managers accumulating shares while 88 reduced their exposure.
Which institutions have been selling or reducing their ORGO positions?
In the latest period, 49 funds trimmed their holdings, and 39 managers completely exited their positions. The aggregate reported sell value was $186.6M.
Are there any notable investors adding ORGO to their portfolios?
Yes, buying activity remains notable. 13 institutions opened new positions in {ticker}, and 34 existing holders added to their shares. The total reported buy value for the quarter amounted to $75.1M.

Related Stocks